Omega Healthcare raises 2024 AFFO guidance to $2.78-$2.84 per share after Q2 gains
Omega Healthcare Investors reported second-quarter 2024 net income of $117 million, or $0.45 per diluted share, up from $62 million, or $0.25, a year earlier, and raised its full-year 2024 Adjusted FFO guidance to $2.78 to $2.84 per share from $2.70 to $2.80. Quarterly Adjusted FFO per share was $0.71, down from $0.74 in the second quarter of 2023.
Key points
- Q2 2024 net income was $117 million ($0.45 diluted per share), versus $62 million ($0.25) in Q2 2023.
- Q2 2024 Adjusted FFO was $185 million ($0.71 per share), versus $183 million ($0.74) in Q2 2023.
- Total revenues were $252.7 million, up from $250.2 million in Q2 2023.
- The company completed $648 million in new investments through July 31, 2024, and LaVie Care Centers filed for Chapter 11 bankruptcy protection in June 2024.
The filing
Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 01, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.